In 2011, researchers identified the potential for study bias regarding results of the use of Bone Morphogenic Protein-2 for lumbar spinal fusion. Medtronic, the manufacturer of Infuse BMP-2, consented to have an independent review of their raw data from all FDA rhBMP2 trials. This study was funded and conducted by The Yale University Open Data […]
The information provided on this website does not provide or should be considered medical advice. It is not a substitute for diagnosis or treatment of any condition. The information provided is for informational purposes only. You should not rely solely on the information provided on this website in making a decision to pursue a specific treatment or advice. You should consult directly with a professional healthcare provider.
As a condition of using the information on this website, Spineopedia.com and its physicians are not responsible for any advice, diagnosis, treatment or outcome you may obtain.
Spineopedia.com is completely self-funded. No outside funds are accepted or used. This website does not utilize paid advertising as a source of revenue.